HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Type-I interferons (IFNs) are vital for antiviral immunity, initiating innate and adaptive responses.
• Viruses have evolved strategies to counteract IFN-mediated signaling to ensure their replication.
• Herpes Simplex Virus type 2 (HSV-2) is known to interfere with host antiviral defenses.

Purpose of the Study:

• To investigate the mechanisms by which HSV-2 subverts type-I IFN-mediated signaling.
• To elucidate the role of STAT2 protein in HSV-2's evasion of the IFN response.
• To differentiate HSV-2's inhibitory strategies based on its replicative cycle phases.

Main Methods:

• Comparative analysis of HSV-2 infection in different cell lines.
• Assessment of STAT2 protein and mRNA levels.
• Evaluation of STAT2 phosphorylation and nuclear translocation.
• Investigation of IFN-signaling pathway activation and antiviral gene expression.

Main Results:

• HSV-2 completely abolished type-1 IFN signaling through multiple STAT2-associated mechanisms.
• Distinct early and late phase inhibition strategies were identified, targeting STAT2 protein or its activation.
• In primary human fibroblasts, HSV-2 utilized both early and late phase mechanisms cooperatively.
• HSV-2 invests significant resources throughout its lifecycle to inhibit STAT2 function.

Conclusions:

• HSV-2 employs sophisticated and adaptable strategies to neutralize STAT2, a key component of the type-I IFN pathway.
• The virus's ability to inhibit STAT2 function is critical for its replication and persistence.
• Understanding these mechanisms provides insights into viral immune evasion and potential therapeutic targets.